XML 28 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Information
 6 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
SEGMENT INFORMATION

NOTE 12 – SEGMENT INFORMATION

 

For the three and six months ended June 30, 2020 and 2019, the Company operated in three reportable business segments - (1) the real property operating segment, (2) the medical related consulting services segment, and (3) the performing development services for hospitals and other customers and sales of developed products to hospitals and other customers segment. The Company's reportable segments are strategic business units that offer different services and products. They are managed separately based on the fundamental differences in their operations. Information with respect to these reportable business segments for the three and six months ended June 30, 2020 and 2019 was as follows:

 

   Three Months Ended
June 30,		   Six Months Ended
June 30,		 
   2020   2019   2020   2019 
Revenues                
Real property operations  $301,267   $264,889   $598,223   $531,515 
Medical related consulting services - related parties   -    111,434    -    125,694 
Development services and sales of developed products   -    23,404    -    26,682 
Total   301,267    399,727    598,223    683,891 
Costs and expenses                    
Real property operations   272,764    192,676    527,265    423,435 
Medical related consulting services - related parties   -    95,375    -    108,466 
Development services and sales of developed products   -    31,784    -    62,091 
Total   272,764    319,835    527,265    593,992 
Gross profit (loss)                    
Real property operations   28,503    72,213    70,958    108,080 
Medical related consulting services - related parties   -    16,059    -    17,228 
Development services and sales of developed products   -    (8,380)   -    (35,409)
Total   28,503    79,892    70,958    89,899 
Other operating expenses                    
Real property operations   103,218    67,691    214,034    177,597 
Medical related consulting services - related parties   175,891    60,943    331,126    240,071 
Development services and sales of developed products   30,240    222,077    66,239    442,958 
Corporate/Other   2,721,981    4,072,933    5,684,578    8,038,338 
Total   3,031,330    4,423,644    6,295,977    8,898,964 
Other income (expense)                    
Interest expense                    
Real property operations   -    (8,219)   -    (32,877)
Corporate/Other   (42,469)   (13,242)   (84,638)   (16,225)
Total   (42,469)   (21,461)   (84,638)   (49,102)
Other income (expense)                    
Real property operations   4    7    (931)   15 
Medical related consulting services - related parties   (11,091)   (9,743)   (16,578)   (21,854)
Development services and sales of developed products   1    51    3    179 
Corporate/Other   -    (63,925)   -    (63,925)
Total   (11,086)   (73,610)   (17,506)   (85,585)
Total other income (expense)   (53,555)   (95,071)   (102,144)   (134,687)
Net loss                    
Real property operations   74,711    3,690    144,007    102,379 
Medical related consulting services - related parties   186,982    54,627    347,704    244,697 
Development services and sales of developed products   30,239    230,406    66,236    478,188 
Corporate/Other   2,764,450    4,150,100    5,769,216    8,118,488 
Total  $3,056,382   $4,438,823   $6,327,163   $8,943,752 

 

Identifiable long-lived tangible assets at June 30, 2020 and December 31, 2019  June 30,
2020		   December 31,
2019		 
Real property operating  $7,668,501   $7,750,743 
Medical related consulting services   232,914    263,621 
Development services and sales of developed products   273,559    322,741 
Total  $8,174,974   $8,337,105 

 

Identifiable long-lived tangible assets at June 30, 2020 and December 31, 2019  June 30,
2020		   December 31,
2019		 
United States  $7,746,413   $7,839,093 
China   428,561    498,012 
Total  $8,174,974   $8,337,105